Quoin Pharmaceuticals, Ltd.
QNRX
$5.91
-$0.16-2.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -18.13% | -0.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.45% | 5.98% | |||
| Operating Income | -12.45% | -5.98% | |||
| Income Before Tax | -10.14% | -6.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.14% | -6.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.14% | -6.83% | |||
| EBIT | -12.45% | -5.98% | |||
| EBITDA | -12.53% | -6.02% | |||
| EPS Basic | 74.03% | -6.83% | |||
| Normalized Basic EPS | 74.03% | -6.82% | |||
| EPS Diluted | 74.06% | -6.67% | |||
| Normalized Diluted EPS | 74.03% | -6.82% | |||
| Average Basic Shares Outstanding | 324.06% | 0.00% | |||
| Average Diluted Shares Outstanding | 323.81% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||